mTOR signaling as a driver of Castleman disease
Blood
.
2020 May 7;135(19):1614-1615.
doi: 10.1182/blood.2020005361.
Author
John D Colgan
1
Affiliation
1
University of Iowa.
PMID:
32379877
DOI:
10.1182/blood.2020005361
No abstract available
Publication types
Comment
MeSH terms
Castleman Disease*
Humans
Signal Transduction
TOR Serine-Threonine Kinases
Substances
MTOR protein, human
TOR Serine-Threonine Kinases